Evaluation of randomized controlled trials

Circulation

Volumn 115, Issue 13, 2007, Pages 1819-1822

  Stanley, Kenneth ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOFIBRATE; PLACEBO; NON PRESCRIPTION DRUG;

ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONFLICT OF INTEREST; CONTROLLED CLINICAL TRIAL; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HIGH RISK POPULATION; HUMAN; INTERVENTION STUDY; MEDICAL LITERATURE; METHODOLOGY; PATIENT COMPLIANCE; PATIENT SAFETY; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RELIABILITY; SENSITIVITY ANALYSIS; STANDARD; TREATMENT OUTCOME; DRUG INTERACTION; EPIDEMIOLOGY; PATIENT; PATIENT SELECTION; PUBLISHING; REPRODUCIBILITY; REVIEW; RISK; STATISTICS;

BIAS (EPIDEMIOLOGY); CONFOUNDING FACTORS (EPIDEMIOLOGY); DRUG INTERACTIONS; DRUGS, NON-PRESCRIPTION; FOLLOW-UP STUDIES; HUMANS; PATIENT DROPOUTS; PATIENT SELECTION; PLACEBO EFFECT; PUBLISHING; RANDOMIZED CONTROLLED TRIALS; REPRODUCIBILITY OF RESULTS; RISK;

EID: 34247203650     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.106.618603     Document Type: Article

References (4)

1. Stanley K. Design of randomized controlled trials. Circulation. 2007;115:9:1164-1169.
2. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet. 2001;357:1191-1194.
3. The Coronary Drug Project Research Group. Influence of adherence to treatment and response of cholesterol on mortality in the Coronary Drug Project. N Engl J Med. 1980;303:1038-1041.
4. DeAngelis C, Drazen JM, Frizelle FA, Haug C, Hoey J, Horton R, Kotzin S, Laine C, Marusic A, Overbeke AJPM, Schroeder TV, Sox HC, Van Der Weyden MB. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. N Engl J Med. 2004;351:1250-1251.